Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues

Antimicrobial peptides (AMPs) are widely distributed throughout the biosphere and represent a class of conserved peptide molecules with intrinsic antimicrobial properties. Their broad-spectrum antimicrobial activity and low risk to induce resistance have led to increased interest in AMPs as potentia...

Full description

Bibliographic Details
Main Authors: Clara Appiah, Shitian Chen, Afia Ibnat Pori, Vladimir Retyunskiy, Chimeng Tzeng, Ye Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1359261/full
_version_ 1797305236661993472
author Clara Appiah
Shitian Chen
Afia Ibnat Pori
Vladimir Retyunskiy
Chimeng Tzeng
Ye Zhao
author_facet Clara Appiah
Shitian Chen
Afia Ibnat Pori
Vladimir Retyunskiy
Chimeng Tzeng
Ye Zhao
author_sort Clara Appiah
collection DOAJ
description Antimicrobial peptides (AMPs) are widely distributed throughout the biosphere and represent a class of conserved peptide molecules with intrinsic antimicrobial properties. Their broad-spectrum antimicrobial activity and low risk to induce resistance have led to increased interest in AMPs as potential alternatives to traditional antibiotics. Among the AMPs, alloferon has been addressed due to its immunomodulatory properties that augment both innate and adaptive immune responses against various pathogens. Alloferon and its analogues have demonstrated pharmaceutical potential through their ability to enhance Natural Killer (NK) cell cytotoxicity and stimulate interferon (IFN) synthesis in both mouse and human models. Additionally, they have shown promise in augmenting antiviral and antitumor activities in mice. In this article, we provide a comprehensive review of the biological effects of alloferon and its analogues, incorporating our own research findings as well. These insights may contribute to a deeper understanding of the therapeutic potential of these novel AMPs.
first_indexed 2024-03-08T00:22:05Z
format Article
id doaj.art-87366a206c704fab9dbb7a12dc668f1f
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-03-08T00:22:05Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-87366a206c704fab9dbb7a12dc668f1f2024-02-16T04:58:50ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122024-02-011510.3389/fphar.2024.13592611359261Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analoguesClara Appiah0Shitian Chen1Afia Ibnat Pori2Vladimir Retyunskiy3Chimeng Tzeng4Ye Zhao5School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, ChinaSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, ChinaSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, ChinaSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, ChinaSchool of Pharmaceutical Sciences, Xiamen University, Xiamen, ChinaSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, ChinaAntimicrobial peptides (AMPs) are widely distributed throughout the biosphere and represent a class of conserved peptide molecules with intrinsic antimicrobial properties. Their broad-spectrum antimicrobial activity and low risk to induce resistance have led to increased interest in AMPs as potential alternatives to traditional antibiotics. Among the AMPs, alloferon has been addressed due to its immunomodulatory properties that augment both innate and adaptive immune responses against various pathogens. Alloferon and its analogues have demonstrated pharmaceutical potential through their ability to enhance Natural Killer (NK) cell cytotoxicity and stimulate interferon (IFN) synthesis in both mouse and human models. Additionally, they have shown promise in augmenting antiviral and antitumor activities in mice. In this article, we provide a comprehensive review of the biological effects of alloferon and its analogues, incorporating our own research findings as well. These insights may contribute to a deeper understanding of the therapeutic potential of these novel AMPs.https://www.frontiersin.org/articles/10.3389/fphar.2024.1359261/fullalloferonantimicrobial peptidesNK cellIFNantivirus
spellingShingle Clara Appiah
Shitian Chen
Afia Ibnat Pori
Vladimir Retyunskiy
Chimeng Tzeng
Ye Zhao
Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues
Frontiers in Pharmacology
alloferon
antimicrobial peptides
NK cell
IFN
antivirus
title Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues
title_full Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues
title_fullStr Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues
title_full_unstemmed Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues
title_short Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues
title_sort study of alloferon a novel immunomodulatory antimicrobial peptide amp and its analogues
topic alloferon
antimicrobial peptides
NK cell
IFN
antivirus
url https://www.frontiersin.org/articles/10.3389/fphar.2024.1359261/full
work_keys_str_mv AT claraappiah studyofalloferonanovelimmunomodulatoryantimicrobialpeptideampanditsanalogues
AT shitianchen studyofalloferonanovelimmunomodulatoryantimicrobialpeptideampanditsanalogues
AT afiaibnatpori studyofalloferonanovelimmunomodulatoryantimicrobialpeptideampanditsanalogues
AT vladimirretyunskiy studyofalloferonanovelimmunomodulatoryantimicrobialpeptideampanditsanalogues
AT chimengtzeng studyofalloferonanovelimmunomodulatoryantimicrobialpeptideampanditsanalogues
AT yezhao studyofalloferonanovelimmunomodulatoryantimicrobialpeptideampanditsanalogues